Copper-Containing Drug Reduces Toxic Proteins In Alzheimer's, Improves Cognition, Study Suggests

Findings published in the American Chemical Society (ACS) Chemical Neuroscience show that a copper-containing compound 'Cu(ATSM)' repairs a vital waste-clearing pump in a mouse model with Alzheimer's disease, potentially unlocking a new avenue of therapeutics targeting neurovascular dysfunction.